Literature DB >> 23646007

Treatment of catamenial epilepsy is still up in the air.

Jacqueline A French.   

Abstract

Entities:  

Year:  2013        PMID： 23646007      PMCID： PMC3639567          DOI： 10.5698/1535-7597-13.2.71

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  5 in total

1.  Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial.

Authors:  A G Herzog; K M Fowler; S D Smithson; L A Kalayjian; C N Heck; M R Sperling; J D Liporace; C L Harden; B A Dworetzky; P B Pennell; J M Massaro
Journal:  Neurology       Date:  2012-05-30       Impact factor: 9.910

2.  Seizure clustering: risks and outcomes.

Authors:  Sheryl R Haut; Shlomo Shinnar; Solomon L Moshé
Journal:  Epilepsia       Date:  2005-01       Impact factor: 5.864

3.  Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders.

Authors:  A G Herzog
Journal:  Neurology       Date:  1986-12       Impact factor: 9.910

4.  Frequency of catamenial seizure exacerbation in women with localization-related epilepsy.

Authors:  Andrew G Herzog; Cynthia L Harden; Joyce Liporace; Page Pennell; Donald L Schomer; Michael Sperling; Kristen Fowler; Blagovast Nikolov; Sevie Shuman; Melanee Newman
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

5.  Progesterone therapy in women with complex partial and secondary generalized seizures.

Authors:  A G Herzog
Journal:  Neurology       Date:  1995-09       Impact factor: 9.910
  5 in total
  1 in total

Review 1.  Women with epilepsy: clinically relevant issues.

Authors:  S Bangar; Abhishek Shastri; Hany El-Sayeh; Andrea E Cavanna
Journal:  Funct Neurol       Date:  2016 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.